EDGAR Filing Documents for 0001193125-09-058636

Form 8-K - Current report:

SEC Accession No. 0001193125-09-058636

Filing Date

2009-03-19

Accepted

2009-03-19 16:18:16

Documents

Period of Report

2009-03-13

Items

Item 2.05: Cost Associated with Exit or Disposal Activities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d8k.htm	8-K	21659
2	FORM OF RETENTION BONUS AGREEMENT	dex10113.htm	EX-10.113	12843
3	PRESS RELEASE OF CORTEX PHARMACEUTICALS, INC.	dex991.htm	EX-99.1	11658
4	GRAPHIC	g86821g70k68.jpg	GRAPHIC	5534
5	GRAPHIC	g86821g81w73.jpg	GRAPHIC	3614
	Complete submission text file	0001193125-09-058636.txt		60598

Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718

Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157

CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)